Credit Suisse Ag Kymera Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 227,586 shares of KYMR stock, worth $9.63 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

227,586

Previous 164,152 38.64%

Holding current value

$9.63 Million

Previous $4.18 Million 118.9%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$22.9 - $43.57 $1.45 Million - $2.76 Million	63,434 Added 38.64%	227,586 $9.15 Million
Q4 2023 Feb 08, 2024	BUY	$10.97 - $26.84 $1.39 Million - $3.4 Million	126,822 Added 339.73%	164,152 $4.18 Million
Q3 2023 Nov 13, 2023	SELL	$13.9 - $23.88 $141,071 - $242,358	-10,149 Reduced 21.38%	37,330 $518,000
Q2 2023 Aug 11, 2023	BUY	$22.4 - $34.92 $272,115 - $424,208	12,148 Added 34.38%	47,479 $1.09 Million
Q1 2023 May 10, 2023	BUY	$24.84 - $38.75 $76,159 - $118,807	3,066 Added 9.5%	35,331 $1.05 Million
Q4 2022 Feb 13, 2023	BUY	$19.57 - $30.92 $12,857 - $20,314	657 Added 2.08%	32,265 $805,000
Q3 2022 Nov 10, 2022	BUY	$20.91 - $34.27 $174,891 - $286,634	8,364 Added 35.98%	31,608 $689,000
Q2 2022 Aug 12, 2022	SELL	$14.13 - $42.55 $861 - $2,595	-61 Reduced 0.26%	23,244 $457,000
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $131,845 - $241,579	3,735 Added 19.09%	23,305 $987,000
Q4 2021 Feb 14, 2022	BUY	$49.91 - $65.56 $148,382 - $194,909	2,973 Added 17.91%	19,570 $1.24 Million
Q3 2021 Nov 12, 2021	BUY	$47.8 - $66.66 $473,506 - $660,333	9,906 Added 148.05%	16,597 $975,000
Q2 2021 Aug 16, 2021	SELL	$31.08 - $51.95 $96,130 - $160,681	-3,093 Reduced 31.61%	6,691 $324,000
Q1 2021 May 14, 2021	SELL	$35.64 - $85.46 $40,380 - $96,826	-1,133 Reduced 10.38%	9,784 $380,000
Q4 2020 Feb 12, 2021	BUY	$28.07 - $87.83 $306,440 - $958,840	10,917 New	10,917 $677,000

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.31B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account